BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24832000)

  • 1. Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
    Penz ED; Mishra EK; Davies HE; Manns BJ; Miller RF; Rahman NM
    Chest; 2014 Oct; 146(4):991-1000. PubMed ID: 24832000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
    Olfert JA; Penz ED; Manns BJ; Mishra EK; Davies HE; Miller RF; Luengo-Fernandez R; Gao S; Rahman NM
    Respirology; 2017 May; 22(4):764-770. PubMed ID: 27983774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
    Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
    JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource Use and Costs of Indwelling Pleural Catheters versus Pleurodesis for Malignant Pleural Effusions: A Population-based Study.
    Kwok C; Thavorn K; Amjadi K; Aaron SD; Kendzerska T
    Ann Am Thorac Soc; 2024 Jun; 21(6):940-948. PubMed ID: 38381853
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
    Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
    Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
    Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
    Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of indwelling pleural catheters for the management of malignant pleural effusion--direct costs in a Dutch hospital.
    Boshuizen RC; Onderwater S; Burgers SJ; van den Heuvel MM
    Respiration; 2013; 86(3):224-8. PubMed ID: 23887083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
    JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
    Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
    BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion.
    Bhatnagar R; Keenan EK; Morley AJ; Kahan BC; Stanton AE; Haris M; Harrison RN; Mustafa RA; Bishop LJ; Ahmed L; West A; Holme J; Evison M; Munavvar M; Sivasothy P; Herre J; Cooper D; Roberts M; Guhan A; Hooper C; Walters J; Saba TS; Chakrabarti B; Gunatilake S; Psallidas I; Walker SP; Bibby AC; Smith S; Stadon LJ; Zahan-Evans NJ; Lee YCG; Harvey JE; Rahman NM; Miller RF; Maskell NA
    N Engl J Med; 2018 Apr; 378(14):1313-1322. PubMed ID: 29617585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis.
    Srour N; Amjadi K; Forster A; Aaron S
    Can Respir J; 2013; 20(2):106-10. PubMed ID: 23616967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent indwelling catheters in the management of pleural effusions.
    Gillen J; Lau C
    Thorac Surg Clin; 2013 Feb; 23(1):63-71, vi. PubMed ID: 23206718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.
    Muruganandan S; Azzopardi M; Fitzgerald DB; Shrestha R; Kwan BCH; Lam DCL; De Chaneet CC; Rashid Ali MRS; Yap E; Tobin CL; Garske LA; Nguyen PT; Stanley C; Popowicz ND; Kosky C; Thomas R; Read CA; Budgeon CA; Feller-Kopman D; Maskell NA; Murray K; Lee YCG
    Lancet Respir Med; 2018 Sep; 6(9):671-680. PubMed ID: 30037711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions.
    MacEachern P; Tremblay A
    Respirology; 2011 Jul; 16(5):747-54. PubMed ID: 21545373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway.
    Ahmed L; Ip H; Rao D; Patel N; Noorzad F
    Chest; 2014 Dec; 146(6):e190-e194. PubMed ID: 25451360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis.
    Olden AM; Holloway R
    J Palliat Med; 2010 Jan; 13(1):59-65. PubMed ID: 19839739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials.
    Wang L; Deng H; Chen X; Li C; Yi F; Wei Y; Zhang W
    World J Surg Oncol; 2020 Jul; 18(1):184. PubMed ID: 32703255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.
    Bhatnagar R; Kahan BC; Morley AJ; Keenan EK; Miller RF; Rahman NM; Maskell NA
    Trials; 2015 Feb; 16():48. PubMed ID: 25880969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.